Home › Stocks › CNSP

CNSP — CNS PHARMACEUTICALS INC

Reported value held$3.69M
Funds holding (latest)49
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)13
Institutional value$1.62M · 305.29K sh
New / Add / Cut / Exit2 / 1 / 4 / 0 · Updated 2026-11-17
Top-5 / Top-10 concentration92.1% / 100.0%
Institutional holdings change Accumulating +1.8% (+5.14K sh)
Institutional value change Up +12.9%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 13 SEC-registered investment managers reported holding CNSP (CNS PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $1.62M across 305.29K shares. That is +1.8% by share count (+5.14K shares) versus the previous quarter, while reported value moved +12.9%. Ownership is concentrated: the five largest holders account for 92.1% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 2 opened new positions, 1 added to existing stakes, 4 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of CNS PHARMACEUTICALS INC (CNSP) include L & S Advisors Inc, Ikarian Capital, LLC, ADAR1 Capital Management, LLC, ranked by reported 13F value among the 49 institutional holders on this page.

CNSP is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 13 305.29K $1.62M +1.8%
Q2 2026 11 280.43K $1.34M +57.8%
Q1 2026 12 145.61K $348.70K +11.3%
Q4 2025 10 117.25K $1.69M -94.0%
Q3 2025 7 10.57K $95.09K -67.4%
Q2 2025 11 512.76K $421.80K +33.5%
Q1 2025 7 40.59K $55.21K -64.1%
Q4 2024 15 2.47M $297.32K +92.0%

Over the 8 quarters shown, institutional share counts decreased 88% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (-94.0%).

Top Institutional Holders (Q3 2026) — 13 funds

FundSharesValuePortfolio WeightChange
Ikarian Capital, LLC 135.83K $719.90K 0.11% Hold
ADAR1 Capital Management, LLC 70.00K $371.00K 0.02% Hold
Stonepine Capital Management, LLC 39.94K $211.69K 0.16% Reduce
Citadel Advisors 19.70K $104.38K 0.00% New
VANGUARD CAPITAL MANAGEMENT LLC 15.76K $83.53K 0.00% Add
BOOTHBAY FUND MANAGEMENT, LLC 13.52K $71.68K 0.00% Hold
VANGUARD FIDUCIARY TRUST CO 10.23K $54.20K 0.00% Hold
Tower Research Capital LLC (TRC) 150 $795 0.00% Reduce
UBS Group AG 130 $689 0.00% Reduce
Fidelity Management & Research (FMR) 26 $136 0.00% New
BARRETT & COMPANY, INC. 8 $42 0.00% Hold
DANSKE BANK A/S 1 $5 0.00% Hold
BARCLAYS PLC 1 $5 0.00% Reduce

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 11 funds

FundSharesValuePortfolio WeightChange
Ikarian Capital, LLC 135.83K $649.27K 0.10% Add
ADAR1 Capital Management, LLC 70.00K $334.60K 0.02% New
Stonepine Capital Management, LLC 41.57K $198.72K 0.13% Reduce
BOOTHBAY FUND MANAGEMENT, LLC 13.52K $64.64K 0.00% Hold
VANGUARD FIDUCIARY TRUST CO 10.23K $48.88K 0.00% New
VANGUARD CAPITAL MANAGEMENT LLC 6.99K $33.43K 0.00% New
UBS Group AG 1.46K $6.98K 0.00% Add
Tower Research Capital LLC (TRC) 799 $3.82K 0.00% Reduce
BARCLAYS PLC 19 $91 0.00% New
BARRETT & COMPANY, INC. 8 $38 0.00% Hold
DANSKE BANK A/S 1 $5 0.00% Hold

Q1 2026 — 12 funds

FundSharesValuePortfolio WeightChange
Stonepine Capital Management, LLC 61.00K $145.79K 0.09% Add
Ikarian Capital, LLC 45.83K $109.99K 0.01% Hold
Geode Capital Management 23.19K $55.65K 0.00% New
BOOTHBAY FUND MANAGEMENT, LLC 13.52K $32.32K 0.00% Hold
Tower Research Capital LLC (TRC) 1.31K $3.13K 0.00% New
UBS Group AG 729 $1.74K 0.00% Add
Sound Income Strategies, LLC 16 $36 0.00% Hold
BARRETT & COMPANY, INC. 8 $19 0.00% Hold
MAI Capital Management 3 $8 0.00% Hold
Citigroup Inc 1 $2 0.00% New
Caitong International Asset Management Co., Ltd 1 $2 0.00% New
DANSKE BANK A/S 1 $2 0.00% Hold

Q4 2025 — 10 funds

FundSharesValuePortfolio WeightChange
L & S Advisors Inc 8.42K $1.12M 0.12% New
Stonepine Capital Management, LLC 48.83K $256.34K 0.20% New
Ikarian Capital, LLC 45.83K $240.61K 0.03% New
BOOTHBAY FUND MANAGEMENT, LLC 13.52K $71.00K 0.00% New
UBS Group AG 611 $3.21K 0.00% Reduce
Sound Income Strategies, LLC 16 $113 0.00% New
BARRETT & COMPANY, INC. 8 $42 0.00% Hold
Bank of America Corp 4 $21 0.00% Hold
MAI Capital Management 3 $16 0.00% Hold
DANSKE BANK A/S 1 $5 0.00% Hold

Q3 2025 — 7 funds

FundSharesValuePortfolio WeightChange
UBS Group AG 10.52K $94.68K 0.00% Reduce
Morgan Stanley 28 $252 0.00% New
BARRETT & COMPANY, INC. 8 $72 0.00% Reduce
Bank of America Corp 4 $36 0.00% Reduce
MAI Capital Management 3 $27 0.00% Reduce
Citigroup Inc 2 $18 0.00% New
DANSKE BANK A/S 1 $9 0.00% New

Q2 2025 — 11 funds

FundSharesValuePortfolio WeightChange
ARMISTICE CAPITAL, LLC 406.00K $334.95K 0.01% New
UBS Group AG 32.10K $26.48K 0.00% Add
Virtu Financial LLC 23.35K $19.00K 0.00% New
Geode Capital Management 17.87K $14.74K 0.00% New
TWO SIGMA SECURITIES, LLC 15.63K $12.90K 0.00% New
HRT FINANCIAL LP 10.86K $8.00K 0.00% New
Tower Research Capital LLC (TRC) 6.74K $5.56K 0.00% Add
BARRETT & COMPANY, INC. 100 $83 0.00% Hold
Bank of America Corp 49 $40 0.00% Add
MAI Capital Management 40 $33 0.00% Hold
SBI Securities Co., Ltd. 13 $11 0.00% Reduce

View all 49 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Ikarian Capital, LLC 135.83K 135.83K 45.83K 45.83K — — — — — — — — — — — — — — — —
ADAR1 Capital Management, LLC 70.00K 70.00K — — — — — — — — — — — — — — — — — —
Stonepine Capital Management, LLC 39.94K 41.57K 61.00K 48.83K — — — — — — — — — — — — — — — —
Citadel Advisors 19.70K — — — — — — 321.87K — — 91.03K — — — 13.20K — — 20.72K 55.23K 81.93K
VANGUARD CAPITAL MANAGEMENT LLC 15.76K 6.99K — — — — — — — — — — — — — — — — — —
BOOTHBAY FUND MANAGEMENT, LLC 13.52K 13.52K 13.52K 13.52K — — — — — — — — — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 10.23K 10.23K — — — — — — — — — — — — — — — — — —
Tower Research Capital LLC (TRC) 150 799 1.31K — — 6.74K 5.11K — 16.30K 115 6.77K 3.98K 4.74K — — — — — — —
UBS Group AG 130 1.46K 729 611 10.52K 32.10K 23.98K 64.42K 181.87K 2.63K — — 55 1.13K 2.46K 1.21K — — — 3.65K
Fidelity Management & Research (FMR) 26 — — — — — — — — 1 14 212 — — 200 — — — — 25
BARRETT & COMPANY, INC. 8 8 8 8 8 100 100 — — — — — — — — — — — — —
BARCLAYS PLC 1 19 — — — — — — — — — — — — — — — — — —
DANSKE BANK A/S 1 1 1 1 1 — — — — — — — — — — — — — — —
L & S Advisors Inc — — — 8.42K — — — — — — — — — — — — — — — —
ARMISTICE CAPITAL, LLC — — — — — 406.00K — — — — 471.00K 122.00K — — — — — — — —
Anson Funds Management LP — — — — — — — — — 141.40K — — — — — — — — — —
Renaissance Technologies — — — — — — — — — — — 11.14K — — 26.80K — 56.80K — 506.53K 147.70K
Vanguard Group — — — — — — — — — — 58.37K 58.37K 23.77K 23.77K — — 453.62K 427.70K 427.70K 609.41K
Geode Capital Management — — 23.19K — — 17.87K — 387.06K 203.18K — 28.25K 24.44K 24.44K 16.14K — — 129.02K 129.02K 129.02K 107.26K
JANE STREET GROUP, LLC — — — — — — — 419.74K 23.16K — 27.39K — — — — — — — — —

Download holders (CSV)

FAQ

Which funds hold CNSP?

As of 2026-Q3, 13 institutional funds reported holding CNSP (CNS PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $1.62M.

How many shares of CNSP do institutions own?

13F filers reported 305.29K shares of CNSP, worth $1.62M in aggregate at the end of 2026-Q3.

Is institutional ownership of CNSP rising or falling?

Share counts moved +1.8% versus the prior quarter — accumulation.

Who are the top institutional holders of CNSP?

The largest 13F holders are L & S Advisors Inc, Ikarian Capital, LLC, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, Anson Funds Management LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of CNS PHARMACEUTICALS INC?

The major shareholders of CNS PHARMACEUTICALS INC (CNSP) by reported 13F value are L & S Advisors Inc, Ikarian Capital, LLC, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, Anson Funds Management LP, among 49 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own CNSP" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/CNSP/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →